Cargando…
MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660
Osteosarcoma (OS) is the most common primary bone malignancy in the adolescent population. MAFG (v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G) forms a heterodimer with Nrf2 (NF-E2-related factor 2), binding to antioxidant response element (ARE), which is required for Nrf2 signaling...
Autores principales: | Shan, Hua-jian, Zhu, Lun-qing, Yao, Chen, Zhang, Zhi-qing, Liu, Yuan-yuan, Jiang, Qin, Zhou, Xiao-zhong, Wang, Xiao-dong, Cao, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039776/ https://www.ncbi.nlm.nih.gov/pubmed/33868783 http://dx.doi.org/10.1016/j.omtn.2021.03.006 |
Ejemplares similares
-
MAFG-AS1 aggravates the progression of pancreatic cancer by sponging miR-3196 to boost NFIX
por: Ye, Liqing, et al.
Publicado: (2020) -
miR-128 Is Implicated in Stress Responses by Targeting MAFG in Skeletal Muscle Cells
por: Caggiano, Rocco, et al.
Publicado: (2017) -
Downregulation of miRNA miR-1305 and upregulation of miRNA miR-6785-5p may be associated with psoriasis
por: Yan, Jianjun, et al.
Publicado: (2022) -
A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2
por: Vera, Olga, et al.
Publicado: (2021) -
LncRNA MAFG-AS1 is involved in human cancer progression
por: Li, Penghui, et al.
Publicado: (2023)